![Bad Blood - John Carreyrou (Alfred A. Knopf - Hardcover) book collectible [Barcode 9781524731656] - Main Image 1](https://www.icollecteverything.com/images/book/main/353/3534911_1.jpg)
![Bad Blood - John Carreyrou (Alfred A. Knopf - Hardcover) book collectible [Barcode 9781524731656] - Main Image 2](https://www.icollecteverything.com/images/book/main/353/3534911_2.jpg)
![Bad Blood - John Carreyrou (Alfred A. Knopf - Hardcover) book collectible [Barcode 9781524731656] - Main Image 3](https://www.icollecteverything.com/images/book/main/353/3534911_3.jpg)
Title:
Bad Blood
Series:
Biographies
Series Order:
0
Binding:
Hardcover
Edition:
1st
Printing:
4th
Narrative:
Third Person
Type of Book:
Fiction
Number of Pages:
352
Number of Chapters:
24
Date Added:
2018-06-26 16:57:05
Synopsis:
NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranos—one of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword.
“Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.
“Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.
Author:
John Carreyrou
Show More
Publisher:
Alfred A. Knopf
Barcode:
9781524731656
Country:
United States
Publication Date:
2018-05-21
Publication Year:
2018
Number of Copies:
1
Publisher Location:
New York
Has Dustcover:
Yes
Automatic Estimated Value:
~$11.75
Automatic Estimated Date:
2026-02-13
Date Added:
2018-06-26 16:57:05
